Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
L Catterton and General Atlantic Lead £280M Investment in Pet Food Brand Butternut Box
L Catterton and General Atlantic led the latest funding round for Butternut Box, a London-based direct-to-consumer dog food brand. The capital is expected to help the company expand its presence in Europe and further afield. According to Sky News, the dog food...
Carlyle Group cashes out on its investment in Saverglass with the $2.16bn sale to Orora
Orora will pay $2.16bn to acquire French glass bottles maker Saverglass from US private equity giant The Carlyle Group as it tilts its business further towards the premium spirits and wine segment. The Melbourne-based glass bottle and aluminium can manufacturer is...
Pure Health buys one of the U.K.’s largest independent hospital operators in a $1.2 billion deal
ADQ, Pure Health’s largest shareholder, is one of the Middle East’s largest holding companies with a broad portfolio of large Abu Dhabi firms. Last week, Pure Health bought one of the U.K.’s largest independent hospital operators in a $1.2bn deal. Circle Health Group...